By David Tuller, DrPH
In a remarkable display of—well, I’m not even sure what to call it–Professor Michael Sharpe has blamed Guardian columnist George Monbiot and Long COVID support groups, among others, for the wave of people reporting prolonged symptoms after acute bouts of COVID-19. And during the same February presentation in which he made those observations, Professor Sharpe warned viewers of “poor quality research” while still citing his beloved but discredited PACE trial as if it offered meaningful evidence. The event was an “Expert Forum on secondary COVID-19 impacts” organized by Swiss Re, a major reinsurance company.
Monbiot himself has experienced what he has referred to as a mild case of Long COVID. He has expressed empathy and support for those who have been whacked by this much, much worse than he has. And the situation has brought to his attention the years-long neglect of the ME/CFS patient community. Here’s part of what he wrote in January in a compelling column:
To read the rest of this story, click on the link below: